 | • レポートコード：QY20ST-00767 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のリドカイン経皮パッチ市場について種類別（リドケア5％経皮パッチ、リドケア1.80％経皮パッチ、リドケア4％経皮パッチ）、用途別（オンライン薬局、病院薬局、クリニック、モノマー薬局、チェーン薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・リドカイン経皮パッチ市場の概要 ・世界の主要地域別リドカイン経皮パッチ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のリドカイン経皮パッチ市場規模2015-2026：種類別（リドケア5％経皮パッチ、リドケア1.80％経皮パッチ、リドケア4％経皮パッチ） ・世界のリドカイン経皮パッチ市場規模2015-2026：用途別（オンライン薬局、病院薬局、クリニック、モノマー薬局、チェーン薬局、その他） ・リドカイン経皮パッチの北米市場規模2015-2020 ・リドカイン経皮パッチのヨーロッパ市場規模2015-2020 ・リドカイン経皮パッチの中国市場規模2015-2020 ・リドカイン経皮パッチの日本市場規模2015-2020 ・リドカイン経皮パッチの東南アジア市場規模2015-2020 ・リドカイン経皮パッチのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・リドカイン経皮パッチの製造コスト分析 ・販売チャネル、流通業者、顧客 ・リドカイン経皮パッチの市場動向・機会・課題 ・調査の結論 |
Lidocaine is chemically known as acetamide, 2- (diethylamino) -n – (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.
Market Analysis and Insights: Global Lidocaine Transdermal Patc Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Lidocaine Transdermal Patc market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Lidocaine Transdermal Patc industry.
Based on our recent survey, we have several different scenarios about the Lidocaine Transdermal Patc YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Lidocaine Transdermal Patc will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Lidocaine Transdermal Patc Scope and Market Size
The global Lidocaine Transdermal Patc market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lidocaine Transdermal Patc market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Lidocaine Transdermal Patc market is segmented into
Lidocare 5% Transdermal Patch
Lidocare 1.80% Transdermal Patch
Lidocare 4% Transdermal Patch
Segment by Application, the Lidocaine Transdermal Patc market is segmented into
Online Pharmacies
Hospital Pharmacies
Clinic
Monomer Pharmacies
Chain Pharmacies
Other
The Lidocaine Transdermal Patc market is analysed and market size information is provided by regions (countries). Segment by Application, the Lidocaine Transdermal Patc market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Lidocaine Transdermal Patc Market Share Analysis
Lidocaine Transdermal Patc market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Lidocaine Transdermal Patc business, the date to enter into the Lidocaine Transdermal Patc market, Lidocaine Transdermal Patc product introduction, recent developments, etc.
The major vendors covered:
Teikoku
Teva Pharmaceutical
Sorrento Therapeutics
Hisamitsu
Endo International
Par Pharmaceutical
Mylan
Tide Pharmaceutical (SINO BIOPHARM)
1 Lidocaine Transdermal Patc Market Overview
1.1 Lidocaine Transdermal Patc Product Scope
1.2 Lidocaine Transdermal Patc Segment by Type
1.2.1 Global Lidocaine Transdermal Patc Sales by Type (2020-2026)
1.2.2 Lidocare 5% Transdermal Patch
1.2.3 Lidocare 1.80% Transdermal Patch
1.2.4 Lidocare 4% Transdermal Patch
1.3 Lidocaine Transdermal Patc Segment by Application
1.3.1 Global Lidocaine Transdermal Patc Sales Comparison by Application (2020-2026)
1.3.2 Online Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Clinic
1.3.5 Monomer Pharmacies
1.3.6 Chain Pharmacies
1.3.7 Other
1.4 Lidocaine Transdermal Patc Market Estimates and Forecasts (2015-2026)
1.4.1 Global Lidocaine Transdermal Patc Sales Growth Rate (2015-2026)
1.4.2 Global Lidocaine Transdermal Patc Revenue and Growth Rate (2015-2026)
1.4.3 Global Lidocaine Transdermal Patc Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Lidocaine Transdermal Patc Industry Impact
1.5.1 How the Covid-19 is Affecting the Lidocaine Transdermal Patc Industry
1.5.1.1 Lidocaine Transdermal Patc Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Lidocaine Transdermal Patc Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Lidocaine Transdermal Patc Players to Combat Covid-19 Impact
2 Lidocaine Transdermal Patc Estimate and Forecast by Region
2.1 Global Lidocaine Transdermal Patc Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Lidocaine Transdermal Patc Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Lidocaine Transdermal Patc Sales Market Share by Region (2015-2020)
2.2.2 Global Lidocaine Transdermal Patc Revenue Market Share by Region (2015-2020)
2.3 Global Lidocaine Transdermal Patc Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Lidocaine Transdermal Patc Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Lidocaine Transdermal Patc Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Lidocaine Transdermal Patc Estimates and Projections (2015-2026)
2.4.2 Europe Lidocaine Transdermal Patc Estimates and Projections (2015-2026)
2.4.3 China Lidocaine Transdermal Patc Estimates and Projections (2015-2026)
2.4.4 Japan Lidocaine Transdermal Patc Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Lidocaine Transdermal Patc Estimates and Projections (2015-2026)
2.4.6 India Lidocaine Transdermal Patc Estimates and Projections (2015-2026)
3 Global Lidocaine Transdermal Patc Competition Landscape by Players
3.1 Global Top Lidocaine Transdermal Patc Players by Sales (2015-2020)
3.2 Global Top Lidocaine Transdermal Patc Players by Revenue (2015-2020)
3.3 Global Lidocaine Transdermal Patc Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lidocaine Transdermal Patc as of 2019)
3.4 Global Lidocaine Transdermal Patc Average Price by Company (2015-2020)
3.5 Manufacturers Lidocaine Transdermal Patc Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Lidocaine Transdermal Patc Players (Opinion Leaders)
4 Global Lidocaine Transdermal Patc Market Size by Type
4.1 Global Lidocaine Transdermal Patc Historic Market Review by Type (2015-2020)
4.1.1 Global Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
4.1.2 Global Lidocaine Transdermal Patc Revenue Market Share by Type (2015-2020)
4.1.3 Global Lidocaine Transdermal Patc Price by Type (2014-2020)
4.2 Global Lidocaine Transdermal Patc Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Lidocaine Transdermal Patc Sales Forecast by Type (2021-2026)
4.2.2 Global Lidocaine Transdermal Patc Revenue Forecast by Type (2021-2026)
4.2.3 Global Lidocaine Transdermal Patc Price Forecast by Type (2021-2026)
5 Global Lidocaine Transdermal Patc Market Size by Application
5.1 Global Lidocaine Transdermal Patc Historic Market Review by Application (2015-2020)
5.1.1 Global Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
5.1.2 Global Lidocaine Transdermal Patc Revenue Market Share by Application (2015-2020)
5.1.3 Global Lidocaine Transdermal Patc Price by Application (2015-2020)
5.2 Global Lidocaine Transdermal Patc Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Lidocaine Transdermal Patc Sales Forecast by Application (2021-2026)
5.2.2 Global Lidocaine Transdermal Patc Revenue Forecast by Application (2021-2026)
5.2.3 Global Lidocaine Transdermal Patc Price Forecast by Application (2021-2026)
3 North America Lidocaine Transdermal Patc Market Facts & Figures
3.2 North America Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
3.3 North America Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
3.4 North America Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
4 Europe Lidocaine Transdermal Patc Market Facts & Figures
4.2 Europe Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
4.3 Europe Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
4.4 Europe Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
5 China Lidocaine Transdermal Patc Market Facts & Figures
5.2 China Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
5.3 China Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
5.4 China Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
6 Japan Lidocaine Transdermal Patc Market Facts & Figures
6.2 Japan Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
6.3 Japan Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
6.4 Japan Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
7 Southeast Asia Lidocaine Transdermal Patc Market Facts & Figures
7.2 Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
8 India Lidocaine Transdermal Patc Market Facts & Figures
8.2 India Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
8.3 India Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
8.4 India Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Lidocaine Transdermal Patc Business
12.1 Teikoku
12.1.1 Teikoku Lidocaine Transdermal Patc Corporation Information
12.1.2 Teikoku Lidocaine Transdermal Patc Business Overview and Total Revenue
12.1.3 Teikoku Lidocaine Transdermal Patc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teikoku Lidocaine Transdermal Patc Products Offered
12.1.5 Teikoku Recent Development
12.2 Teva Pharmaceutical
12.2.1 Teva Pharmaceutical Lidocaine Transdermal Patc Corporation Information
12.2.2 Teva Pharmaceutical Lidocaine Transdermal Patc Business Overview and Total Revenue
12.2.3 Teva Pharmaceutical Lidocaine Transdermal Patc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Pharmaceutical Lidocaine Transdermal Patc Products Offered
12.2.5 Teva Pharmaceutical Recent Development
12.3 Sorrento Therapeutics
12.3.1 Sorrento Therapeutics Lidocaine Transdermal Patc Corporation Information
12.3.2 Sorrento Therapeutics Lidocaine Transdermal Patc Business Overview and Total Revenue
12.3.3 Sorrento Therapeutics Lidocaine Transdermal Patc Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sorrento Therapeutics Lidocaine Transdermal Patc Products Offered
12.3.5 Sorrento Therapeutics Recent Development
12.4 Hisamitsu
12.4.1 Hisamitsu Lidocaine Transdermal Patc Corporation Information
12.4.2 Hisamitsu Lidocaine Transdermal Patc Business Overview and Total Revenue
12.4.3 Hisamitsu Lidocaine Transdermal Patc Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hisamitsu Lidocaine Transdermal Patc Products Offered
12.4.5 Hisamitsu Recent Development
12.5 Endo International
12.5.1 Endo International Lidocaine Transdermal Patc Corporation Information
12.5.2 Endo International Lidocaine Transdermal Patc Business Overview and Total Revenue
12.5.3 Endo International Lidocaine Transdermal Patc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Endo International Lidocaine Transdermal Patc Products Offered
12.5.5 Endo International Recent Development
12.6 Par Pharmaceutical
12.6.1 Par Pharmaceutical Lidocaine Transdermal Patc Corporation Information
12.6.2 Par Pharmaceutical Lidocaine Transdermal Patc Business Overview and Total Revenue
12.6.3 Par Pharmaceutical Lidocaine Transdermal Patc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Par Pharmaceutical Lidocaine Transdermal Patc Products Offered
12.6.5 Par Pharmaceutical Recent Development
12.7 Mylan
12.7.1 Mylan Lidocaine Transdermal Patc Corporation Information
12.7.2 Mylan Lidocaine Transdermal Patc Business Overview and Total Revenue
12.7.3 Mylan Lidocaine Transdermal Patc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Mylan Lidocaine Transdermal Patc Products Offered
12.7.5 Mylan Recent Development
12.8 Tide Pharmaceutical (SINO BIOPHARM)
12.8.1 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patc Corporation Information
12.8.2 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patc Business Overview and Total Revenue
12.8.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patc Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patc Products Offered
12.8.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Development
13 Lidocaine Transdermal Patc Manufacturing Cost Analysis
13.1 Lidocaine Transdermal Patc Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Lidocaine Transdermal Patc
13.4 Lidocaine Transdermal Patc Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Lidocaine Transdermal Patc Distributors List
14.3 Lidocaine Transdermal Patc Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Lidocaine Transdermal Patc Sales (M Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Lidocaine Transdermal Patc Sales (M Pcs) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Lidocaine Transdermal Patc Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Lidocaine Transdermal Patc Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Lidocaine Transdermal Patc Players to Combat Covid-19 Impact
Table 8. Global Market Lidocaine Transdermal Patc Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Lidocaine Transdermal Patc Sales (M Pcs) by Region (2015-2020)
Table 10. Global Lidocaine Transdermal Patc Sales Market Share by Region (2015-2020)
Table 11. Global Lidocaine Transdermal Patc Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Lidocaine Transdermal Patc Revenue Share by Region (2015-2020)
Table 13. Global Lidocaine Transdermal Patc Sales (M Pcs) Forecast by Region (2021-2026)
Table 14. Global Lidocaine Transdermal Patc Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Lidocaine Transdermal Patc Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Lidocaine Transdermal Patc Revenue Share Forecast by Region (2021-2026)
Table 17. Global Lidocaine Transdermal Patc (M Pcs) of Key Companies (2015-2020)
Table 18. Global Lidocaine Transdermal Patc Sales Share by Company (2015-2020)
Table 19. Global Lidocaine Transdermal Patc Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Lidocaine Transdermal Patc Revenue Share by Company (2015-2020)
Table 21. Global Lidocaine Transdermal Patc by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lidocaine Transdermal Patc as of 2019)
Table 22. Global Lidocaine Transdermal Patc Average Price (USD/K Pcs) of Key Company (2015-2020)
Table 23. Manufacturers Lidocaine Transdermal Patc Manufacturing Sites and Area Served
Table 24. Manufacturers Lidocaine Transdermal Patc Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Lidocaine Transdermal Patc Players
Table 27. Global Lidocaine Transdermal Patc Sales (M Pcs) by Type (2015-2020)
Table 28. Global Lidocaine Transdermal Patc Sales Share by Type (2015-2020)
Table 29. Global Lidocaine Transdermal Patc Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Lidocaine Transdermal Patc Price (M Pcs) by Type (2015-2020)
Table 31. Global Lidocaine Transdermal Patc Sales Share by Type (2021-2026)
Table 32. Global Lidocaine Transdermal Patc Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Lidocaine Transdermal Patc Revenue Share by Type (2021-2026)
Table 34. Global Lidocaine Transdermal Patc Price (M Pcs) by Type (2021-2026)
Table 35. Global Lidocaine Transdermal Patc Sales (M Pcs) by Application (2015-2020)
Table 36. Global Lidocaine Transdermal Patc Sales Share by Application (2015-2020)
Table 37. Global Lidocaine Transdermal Patc Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Lidocaine Transdermal Patc Price (M Pcs) by Application (2015-2020)
Table 39. Global Lidocaine Transdermal Patc Sales (M Pcs) by Application (2021-2026)
Table 40. Global Lidocaine Transdermal Patc Sales Share by Application (2021-2026)
Table 41. Global Lidocaine Transdermal Patc Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Lidocaine Transdermal Patc Revenue Share by Application (2021-2026)
Table 43. Global Lidocaine Transdermal Patc Price (M Pcs) by Application (2021-2026)
Table 44. United States Lidocaine Transdermal Patc Sales (M Pcs) by Company (2015-2020)
Table 45. United States Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
Table 46. United States Lidocaine Transdermal Patc Sales (M Pcs) by Type (2015-2020)
Table 47. United States Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
Table 48. United States Lidocaine Transdermal Patc Sales (M Pcs) by Application (2015-2020)
Table 49. United States Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
Table 50. Europe Lidocaine Transdermal Patc Sales (M Pcs) by Company (2015-2020)
Table 51. Europe Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
Table 52. Europe Lidocaine Transdermal Patc Sales (M Pcs) by Type (2015-2020)
Table 53. Europe Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
Table 54. Europe Lidocaine Transdermal Patc Sales (M Pcs) by Application (2015-2020)
Table 55. Europe Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
Table 56. China Lidocaine Transdermal Patc Sales (M Pcs) by Company (2015-2020)
Table 57. China Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
Table 58. China Lidocaine Transdermal Patc Sales (M Pcs) by Type (2015-2020)
Table 59. China Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
Table 60. China Lidocaine Transdermal Patc Sales (M Pcs) by Application (2015-2020)
Table 61. China Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
Table 62. Japan Lidocaine Transdermal Patc Sales (M Pcs) by Company (2015-2020)
Table 63. Japan Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
Table 64. Japan Lidocaine Transdermal Patc Sales (M Pcs) by Type (2015-2020)
Table 65. Japan Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
Table 66. Japan Lidocaine Transdermal Patc Sales (M Pcs) by Application (2015-2020)
Table 67. Japan Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Lidocaine Transdermal Patc Sales (M Pcs) by Company (2015-2020)
Table 69. Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Lidocaine Transdermal Patc Sales (M Pcs) by Type (2015-2020)
Table 71. Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Lidocaine Transdermal Patc Sales (M Pcs) by Type (2015-2020)
Table 73. Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
Table 74. India Lidocaine Transdermal Patc Sales (M Pcs) by Company (2015-2020)
Table 75. India Lidocaine Transdermal Patc Sales Market Share by Company (2015-2020)
Table 76. India Lidocaine Transdermal Patc Sales (M Pcs) by Type (2015-2020)
Table 77. India Lidocaine Transdermal Patc Sales Market Share by Type (2015-2020)
Table 78. India Lidocaine Transdermal Patc Sales (M Pcs) by Application (2015-2020)
Table 79. India Lidocaine Transdermal Patc Sales Market Share by Application (2015-2020)
Table 80. Teikoku Corporation Information
Table 81. Teikoku Description and Business Overview
Table 82. Teikoku Lidocaine Transdermal Patc Sales (M Pcs), Revenue (Million USD), Price (USD/K Pcs) and Gross Margin (2015-2020)
Table 83. Teikoku Lidocaine Transdermal Patc Product
Table 84. Teikoku Recent Development
Table 85. Teva Pharmaceutical Corporation Information
Table 86. Teva Pharmaceutical Description and Business Overview
Table 87. Teva Pharmaceutical Lidocaine Transdermal Patc Sales (M Pcs), Revenue (Million USD), Price (USD/K Pcs) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceutical Lidocaine Transdermal Patc Product
Table 89. Teva Pharmaceutical Recent Development
Table 90. Sorrento Therapeutics Corporation Information
Table 91. Sorrento Therapeutics Description and Business Overview
Table 92. Sorrento Therapeutics Lidocaine Transdermal Patc Sales (M Pcs), Revenue (Million USD), Price (USD/K Pcs) and Gross Margin (2015-2020)
Table 93. Sorrento Therapeutics Lidocaine Transdermal Patc Product
Table 94. Sorrento Therapeutics Recent Development
Table 95. Hisamitsu Corporation Information
Table 96. Hisamitsu Description and Business Overview
Table 97. Hisamitsu Lidocaine Transdermal Patc Sales (M Pcs), Revenue (Million USD), Price (USD/K Pcs) and Gross Margin (2015-2020)
Table 98. Hisamitsu Lidocaine Transdermal Patc Product
Table 99. Hisamitsu Recent Development
Table 100. Endo International Corporation Information
Table 101. Endo International Description and Business Overview
Table 102. Endo International Lidocaine Transdermal Patc Sales (M Pcs), Revenue (Million USD), Price (USD/K Pcs) and Gross Margin (2015-2020)
Table 103. Endo International Lidocaine Transdermal Patc Product
Table 104. Endo International Recent Development
Table 105. Par Pharmaceutical Corporation Information
Table 106. Par Pharmaceutical Description and Business Overview
Table 107. Par Pharmaceutical Lidocaine Transdermal Patc Sales (M Pcs), Revenue (Million USD), Price (USD/K Pcs) and Gross Margin (2015-2020)
Table 108. Par Pharmaceutical Lidocaine Transdermal Patc Product
Table 109. Par Pharmaceutical Recent Development
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Lidocaine Transdermal Patc Sales (M Pcs), Revenue (Million USD), Price (USD/K Pcs) and Gross Margin (2015-2020)
Table 113. Mylan Lidocaine Transdermal Patc Product
Table 114. Mylan Recent Development
Table . Tide Pharmaceutical (SINO BIOPHARM) Corporation Information
Table . Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patc Sales (M Pcs), Revenue (Million USD), Price (USD/K Pcs) and Gross Margin (2015-2020)
Table . Tide Pharmaceutical (SINO BIOPHARM) Description and Business Overview
Table . Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patc Product
Table . Tide Pharmaceutical (SINO BIOPHARM) Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Lidocaine Transdermal Patc Distributors List
Table 123. Lidocaine Transdermal Patc Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Lidocaine Transdermal Patc Product Picture
Figure 2. Global Lidocaine Transdermal Patc Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Lidocaine Transdermal Patc Market Share by Application in 2020 & 2026
Figure 6. Online Pharmacies Examples
Figure 7. Hospital Pharmacies Examples
Figure 8. Clinic Examples
Figure 9. Monomer Pharmacies Examples
Figure 10. Chain Pharmacies Examples
Figure 11. Other Examples
Figure 12. Global Lidocaine Transdermal Patc Sales (M Pcs) Growth Rate (2015-2026)
Figure 13. Global Lidocaine Transdermal Patc Revenue (US$ Million) Growth Rate (2015-2026)
Figure 14. Global Lidocaine Transdermal Patc Price Trends Growth Rate (2015-2026) (USD/K Pcs)
Figure 15. Global Lidocaine Transdermal Patc Revenue Market Share by Region: 2015 VS 2020
Figure 16. Global Lidocaine Transdermal Patc Revenue Market Share by Region: 2021 VS 2026
Figure 17. United States Lidocaine Transdermal Patc Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. United States Lidocaine Transdermal Patc Sales (M Pcs) Growth Rate (2015-2026)
Figure 19. Europe Lidocaine Transdermal Patc Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Europe Lidocaine Transdermal Patc Sales (Million USD) Growth Rate (2015-2026)
Figure 21. China Lidocaine Transdermal Patc Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. China Lidocaine Transdermal Patc Sales (Million USD) and Growth Rate (2015-2026)
Figure 23. Japan Lidocaine Transdermal Patc Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Japan Lidocaine Transdermal Patc Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Lidocaine Transdermal Patc Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Lidocaine Transdermal Patc Sales (Million USD) Growth Rate (2015-2026)
Figure 27. India Lidocaine Transdermal Patc Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. India Lidocaine Transdermal Patc Sales (Million USD) Growth Rate (2015-2026)
Figure 29. Global 5 Largest Lidocaine Transdermal Patc Players Market Share by Revenue in Lidocaine Transdermal Patc 2015 & 2019
Figure 30. Lidocaine Transdermal Patc Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Lidocaine Transdermal Patc Revenue Share by Type (2015-2020)
Figure 32. Global Lidocaine Transdermal Patc Revenue Growth Rate by Type in 2015 & 2019
Figure 33. Global Lidocaine Transdermal Patc Revenue Share by Application (2015-2020)
Figure 34. Global Lidocaine Transdermal Patc Revenue Growth Rate by Application in 2015 & 2019
Figure 35. United States Lidocaine Transdermal Patc Sales Market Share by Type in 2019
Figure 36. United States Lidocaine Transdermal Patc Sales Market Share by Type in 2019
Figure 37. Europe Lidocaine Transdermal Patc Sales Market Share by Company in 2019
Figure 38. Europe Lidocaine Transdermal Patc Sales Market Share by Type in 2019
Figure 39. Europe Lidocaine Transdermal Patc Sales Market Share by Application in 2019
Figure 40. China Lidocaine Transdermal Patc Sales Market Share by Company in 2019
Figure 41. China Lidocaine Transdermal Patc Sales Market Share by Type in 2019
Figure 42. China Lidocaine Transdermal Patc Sales Market Share by Application in 2019
Figure 43. Japan Lidocaine Transdermal Patc Sales Market Share by Company in 2019
Figure 44. Japan Lidocaine Transdermal Patc Sales Market Share by Type in 2019
Figure 45. Japan Lidocaine Transdermal Patc Sales Market Share by Application in 2019
Figure 46. Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Company in 2019
Figure 47. Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Type in 2019
Figure 48. Southeast Asia Lidocaine Transdermal Patc Sales Market Share by Application in 2019
Figure 49. India Lidocaine Transdermal Patc Sales Market Share by Company in 2019
Figure 50. India Lidocaine Transdermal Patc Sales Market Share by Type in 2019
Figure 51. India Lidocaine Transdermal Patc Sales Market Share by Application in 2019
Figure 52. Teikoku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Hisamitsu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Par Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Tide Pharmaceutical (SINO BIOPHARM) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Lidocaine Transdermal Patc
Figure 62. Manufacturing Process Analysis of Lidocaine Transdermal Patc
Figure 63. Lidocaine Transdermal Patc Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
経皮/経粘膜ドラッグデリバリーシステムの世界市場レポート2020 A recently published report by QY Research titled Global Transdermal/Transmucosal Drug Delivery System Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stat…- TDS（経皮デリバリーシステム）の世界市場レポート2020 Market Analysis and Insights: Global TDS(Transdermal Delivery Systems) Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coron…
- 経皮治療システム（TTS）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Transdermal Therapeutic Systems (TTS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- テトラカインの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tetracaine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tetracaine market report provides …
- テトラカインの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tetracaine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tetracaine market report provides …